BCS and IVIVC Based Biowaivers

Biosimilars Congress 2019 is included Keynote and Speakers sessions on the most recent examination intended to offer extensive worldwide exchanges that address current issues in Biosimilars Congress 2019

The goal of this work was to propose the biowaivers capability of biopharmaceutical order framework which is known to build the dissolvability, disintegration, oral assimilation of water insoluble medications. Biopharmaceutics Classification System and invitro and invivo order examines about ADME pathways of various medications. This additionally incorporates BCS biowaivers, In vitro dissemination cells for disintegration testing in detailing improvement, In vitro preclinical ADME/BCS testing.

·         Preclinical and clinical testing for oral drug delivery

·         Waiver for In vivo bioavailability or bioequivalence

·         Consideration of biowaiver extensions for BCS class III drugs

·  In vitro diffusion cells for dissolution testing in formulation development

·         Dissolution testing in drug formulation

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.